SLGL Stock Analysis: Buy, Sell, or Hold?
SLGL - Sol-Gel Technologies Ltd. Ordinary Shares
$71.50
-2.23 (-3.02%)
▼
5d:
-3.12%
30d:
-7.98%
90d:
-19.12%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 22, 2026
0d
Get Alerted When SLGL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called SLGL this week
0% bullish • 1 bearish
0% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SLGL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SLGL shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SLGL is currently trading at $71.50, which is considered fair relative to its 30-day fair value range of $68.34 to $75.28.
Technical Outlook: Technically, SLGL is showing sideways momentum. Immediate support is located at $63.18, while resistance sits at $81.53. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: SLGL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $147.00 (+105.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SLGL is showing sideways momentum. Immediate support is located at $63.18, while resistance sits at $81.53. Short-term momentum is weak, with the stock down 3.0% recently.
Market Sentiment: SLGL has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $147.00 (+105.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$68.34 -
$75.28
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.0%)
- BULLISH: Trading 105.6% below Wall St target ($147.00)
Trading Range Analysis
30-Day Trading Range
$68.34 -
$75.28
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$63.18
Resistance Level
$81.53
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.57
Wall Street Target
$147.00
(+105.6%)
Revenue Growth (YoY)
150.4%
Earnings Growth (YoY)
487.6%
Profit Margin
-31.6%
Share & Embed Analysis
Last updated: June 04, 2026 4:11 AM ET
Data refreshes hourly during market hours. Next update: 5:11 AM
Data refreshes hourly during market hours. Next update: 5:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SLGL showing a specific setup today?
Insider Activity (6 Months)
10
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Opaleye Management Inc.
BUY
100 shares
2026-01-27
Opaleye Management Inc.
BUY
1151 shares
2026-01-23
Opaleye Management Inc.
BUY
2173 shares
2026-01-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 66 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 53 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 55 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 53 HOLD |
|
RNA
Atrium Therapeutics, Inc… |
STRONG BUY
15 analysts |
$25 | 59 HOLD |
